Sarilumab for moderate to severe rheumatoid arthritis

  • Technology appraisal guidance
  • TA485
  • Published: 
Download guidance (PDF)

Update information

December 2020: Recommendation 1.4 updated to clarify when sarilumab can be used as monotherapy. Recommendation 1.6 added to ensure equality when using the DAS28.

ISBN: 978-1-4731-1709-9